Tongxinluo Capsule for Coronary Microvascular Disease

Summary

To investigate the efficacy and safety of Tongxinluo in patients with microvascular angina pectoris. Long-term follow-up of 1 to 5 years will be performed to evaluate the effect of Tongxinluo on long-term adverse cardiovascular events in patients with coronary microvascular disease.

Timeline

Start

2020-01

Primary completion

2021-01

Completion

2025-01

Drugs

Indications